Back to Search Start Over

Cardiac Magnetic Resonance Imaging to Determine Single Ventricle Function in a Pediatric Population is Feasible in a Large Trial Setting: Experience from the Single Ventricle Reconstruction Trial Longitudinal Follow up.

Authors :
Detterich J
Taylor MD
Slesnick TC
DiLorenzo M
Hlavacek A
Lam CZ
Sachdeva S
Lang SM
Campbell MJ
Gerardin J
Whitehead KK
Rathod RH
Cartoski M
Menon S
Trachtenberg F
Gongwer R
Newburger J
Goldberg C
Dorfman AL
Source :
Pediatric cardiology [Pediatr Cardiol] 2023 Oct; Vol. 44 (7), pp. 1454-1461. Date of Electronic Publication: 2023 Jul 05.
Publication Year :
2023

Abstract

The Single Ventricle Reconstruction (SVR) Trial was a randomized prospective trial designed to determine survival advantage of the modified Blalock-Taussig-Thomas shunt (BTTS) vs the right ventricle to pulmonary artery conduit (RVPAS) for patients with hypoplastic left heart syndrome. The primary aim of the long-term follow-up (SVRIII) was to determine the impact of shunt type on RV function. In this work, we describe the use of CMR in a large cohort follow up from the SVR Trial as a focused study of single ventricle function. The SVRIII protocol included short axis steady-state free precession imaging to assess single ventricle systolic function and flow quantification. There were 313 eligible SVRIII participants and 237 enrolled, ages ranging from 10 to 12.5 years. 177/237 (75%) participants underwent CMR. The most common reasons for not undergoing CMR exam were requirement for anesthesia (nā€‰=ā€‰14) or ICD/pacemaker (nā€‰=ā€‰11). A total of 168/177 (94%) CMR studies were diagnostic for RVEF. Median exam time was 54 [IQR 40-74] minutes, cine function exam time 20 [IQR 14-27] minutes, and flow quantification time 18 [IQR 12-25] minutes. There were 69/177 (39%) studies noted to have intra-thoracic artifacts, most common being susceptibility artifact from intra-thoracic metal. Not all artifacts resulted in non-diagnostic exams. These data describe the use and limitations of CMR for the assessment of cardiac function in a prospective trial setting in a grade-school-aged pediatric population with congenital heart disease. Many of the limitations are expected to decrease with the continued advancement of CMR technology.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
1432-1971
Volume :
44
Issue :
7
Database :
MEDLINE
Journal :
Pediatric cardiology
Publication Type :
Academic Journal
Accession number :
37405456
Full Text :
https://doi.org/10.1007/s00246-023-03216-8